board data analysis founder networking 
Angel Capital Association
JANUARY 3, 2024
Angels often make their first real impact post-investment by helping a portfolio company develop a “real” Board, by insisting on documented processes, key metrics and measures and a more rigorous approach to corporate oversight and accountability. In the latter case, returns improved by 20%. with an average of 5.7 Director seats.
HPA
MARCH 21, 2024
Focusing on mission-critical energy needs across industries like data centers, construction, and transportation. Fuel Me provides efficient fuel operations through an aggregated nationwide fuel procurement vendor network. and global energy markets,” said Carlo Passacantando, Founder and CEO. Full press release here.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Paul G. Silva
FEBRUARY 6, 2024
Example For the entertainment data client that approached PixelEdge, they already had data and technology. They had an investment information tool for their space, including research and data analysis. They have great internal resources and a large external network to work with.
AsiaTechDaily
MAY 9, 2022
The program supports startups financially and gives them multiple opportunities to network with top tech companies, VCs, mentors, etc. During KSGC 2021, Khenda got introduced to prominent Korean businessman Dong Hoon Shin, who eventually joined the company’s advisory board. ” said Aykan Ekici, co-founder of Khenda.
AsiaTechDaily
MAY 25, 2022
month program supports startups financially and gives them multiple opportunities to network with top tech companies, VCs, mentors, etc. Shin is now part of our Advisory Board,” said Aykan Ekici, co-founder of Khenda, the top winner of KSGC 2021.
OurCrowd
MARCH 25, 2022
Ciechanover will join me for Investing in Precision Medicine , an online event hosted by OurCrowd on March 28th, alongside David (Dudi) Baum, Co-Founder and CEO of Genopore ; Ophir Herbst, Co-Founder and CEO of Sequentify ; Dr. Ofer Sharon, CEO of OncoHost ; and Dr. Liran Shlush, Senior Scientist at the Weizmann Institute. Invest Now.
OurCrowd
MARCH 25, 2022
Ciechanover will join me for Investing in Precision Medicine , an online event hosted by OurCrowd on March 28th, alongside David (Dudi) Baum, Co-Founder and CEO of Genopore ; Ophir Herbst, Co-Founder and CEO of Sequentify ; Dr. Ofer Sharon, CEO of OncoHost ; and Dr. Liran Shlush, Senior Scientist at the Weizmann Institute. Invest Now.
Expert insights. Personalized for you.
52 
Let's personalize your content